RESTORE Trial: Lung Cancer Screening Support for Black Individuals
This study, called the RESTORE trial, is testing a special decision-making support program for Black individuals to see if it increases their participation in lung cancer screening (LCS). Lung cancer is a major health concern for Black men and women. LCS, which uses yearly low-dose CT scans, is recommended for people aged 50-80 with a history of smoking. While LCS can significantly reduce lung cancer deaths, many minority groups don't complete it. This program is designed specifically for Black individuals to address their needs. To join, you must identify as Black or African American, be between 50-77 years old, have smoked for at least 20 pack-years, and have used commercial tobacco within the last 15 years. You should not have had a chest CT in the past year or a personal history of lung cancer. The study will measure how acceptable the program is and how much participants learn about LCS.
- Study design
- This study is an interventional study with a planned enrollment of 45 participants. It is testing an educational intervention.
- What's involved
- Participants will attend an in-person decision-making support session lasting 2-3 hours.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants may be followed up at 90 days after completing the study intervention.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Matthew Triplette, MD, MPH · PRINCIPAL_INVESTIGATOR · Fred Hutch/University of Washington Cancer Consortium
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Intervention acceptabilityAt post-intervention (Day 1)
Assessed using the Acceptability of Intervention Measure (AIM). The AIM will be summarized and presented as a range of scores from 1 (low acceptability/appropriateness) to 5 (high acceptability/appropriateness).
- Lung cancer screening knowledgeAt pre- and post-intervention (both on Day 1)
Will be assessed using the Lung Cancer Screening Knowledge 7 question score. Pre- and post-intervention responses will be compared via Chochran-Mantel-Haenszel and Friedman tests.